OVERLAND PARK, Kan.; August 2, 2023 – Dr. Vince Clinical Research (DVCR), a full-service CRO specializing in Phase I-II clinical trials, announced today the first subject was screened for Cessation Therapeutics’ CSX-1004 in a First-In-Human single ascending dose study...
OVERLAND PARK, Kan.; June 27, 2023 (Business Wire) – Dr. Vince Clinical Research, a full-service Phase I-II contract research organization (CRO), announced its world-class clinical pharmacology unit, which opened in September, was awarded two Green Globes...
At Dr. Vince Clinical Research we offer full-service Phase I-II trial execution that not only generates SMARTER FASTER DATA®, but does so through a building design that promotes greater overall wellness and long-term environmental sustainability. In order to discover...
DVCR now manages multi-site studies across a diverse range of therapeutic areas and trial types. With a network of strategically qualified sites across North America, we ensure that your study is being conducted by the most capable sites and Principal Investigators in...
Recent Comments